SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 115 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $4,853,000 | -29.4% | 450,000 | 0.0% | 0.66% | -23.9% |
| Q2 2014 | $6,871,000 | -15.5% | 450,000 | 0.0% | 0.87% | -3.4% |
| Q1 2014 | $8,136,000 | -65.4% | 450,000 | -73.4% | 0.90% | -64.3% |
| Q4 2013 | $23,535,000 | +30.6% | 1,694,401 | -1.5% | 2.52% | +14.1% |
| Q3 2013 | $18,019,000 | +30.8% | 1,719,401 | -2.5% | 2.21% | +19.1% |
| Q2 2013 | $13,773,000 | – | 1,763,503 | – | 1.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |